Aminoglycoside - info-atbvac

info-atbvac > Aminoglycoside

Aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis : reassuring data. ( Meital Elbaz et al. )

Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis.

25 juin | Dr Philippe Lesprit

Aminoglycosides are usually recommended only as second line therapy for the treatment of acute pyelonephritis. However they offer several advantages … Suite

Does short course adjunctive aminoglycoside therapy improve mortality in Gram-negative bloodstream infection? ( J W Timotëus Deelen et al. )

Short course aminoglycosides as adjunctive empiric therapy in patients with Gram negative bloodstream infection, a cohort study.

23 juin | Dr Jean-Pierre Bru

Short-course combination therapy with aminoglycoside in patients with sepsis or septic shock is still a matter of debate. Arguments for … Suite

Benzyl-pénicilline + aminoside moins efficace que méropénème pour les neutropénies prolongées fébriles au Danemark ( Torfoss D. et al )

Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial.

28 mar | Pr Pierre Tattevin

L’épargne des carbapénèmes et l’usage d’antibiotiques au spectre le plus étroit possible rencontrent parfois leurs limites. Dans cette étude randomisée … Suite